Microglial CD14 activated by iNOS contributes to neuroinflammation in cerebral ischemia

Brain Research

Volumn 1506, Issue , 2013, Pages 105-114

  Zhou, Mian ^a   Wang, Christie M ^a   Yang, Weng Lang ^a   Wang, Ping ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

CD14; Cerebral ischemia; iNOS; l canavanine; Microglia; TNF

Indexed keywords

3 NITROTYROSINE; CANAVANINE; CD14 ANTIGEN; I KAPPA B; INDUCIBLE NITRIC OXIDE SYNTHASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL HYPOXIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ENZYME ACTIVATION; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; ANTIGENS, CD14; BLOTTING, WESTERN; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

MURINAE; MUS;

EID: 84875736874     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.02.010     Document Type: Article

References (57)

1. B. Arvin, L.F. Neville, F.C. Barone, and G.Z. Feuerstein The role of inflammation and cytokines in brain injury Neurosci. Biobehav. Rev. 20 1996 445 452
2. S. Ashwal, D.J. Cole, S. Osborne, T.N. Osborne, and W.J. Pearce l-NAME reduces infarct volume in a filament model of transient middle cerebral artery occlusion in the rat pup Pediatr. Res. 38 1995 652 656
3. P.A. Baeuerle, and D. Baltimore Ikappa B: a specific inhibitor of the NF-kappa B transcription factor Science 242 1988 540 546
4. R.C. Barber, D.L. Maass, D.J. White, L.Y. Chang, and J.W. Horton Molecular or pharmacologic inhibition of the CD14 signaling pathway protects against burn-related myocardial inflammation and dysfunction Shock 30 2008 705 713
5. F.C. Barone, B. Arvin, R.F. White, A. Miller, C.L. Webb, R.N. Willette, P.G. Lysko, and G.Z. Feuerstein Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury Stroke 28 1997 1233 1244
6. L. Belayev, O.F. Alonso, R. Busto, W. Zhao, and M.D. Ginsberg Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model Stroke 27 1996 1616 1622
7. R. Beschorner, H.J. Schluesener, F. Gozalan, R. Meyermann, and J.M. Schwab Infiltrating CD14+ monocytes and expression of CD14 by activated parenchymal microglia/macrophages contribute to the pool of CD14+ cells in ischemic brain lesions J. Neuroimmunol 126 2002 107 115
8. R. Beschorner, T.D. Nguyen, F. Gozalan, I. Pedal, R. Mattern, H.J. Schluesener, R. Meyermann, and J.M. Schwab CD14 expression by activated parenchymal microglia/macrophages and infiltrating monocytes following human traumatic brain injury Acta Neuropathol. 103 2002 541 549
9. J.P. Bolanos, and A. Almeida Roles of nitric oxide in brain hypoxia-ischemia Biochim. Biophys. Acta 1411 1999 415 436
10. E. Bonfoco, D. Krainc, M. Ankarcrona, P. Nicotera, and S.A. Lipton Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures Proc. Natl. Acad. Sci. U.S.A. 92 1995 7162 7166
11. S. Camandola, and M.P. Mattson NF-kappa B as a therapeutic target in neurodegenerative diseases Expert Opin. Ther. Targets 11 2007 123 132
12. S. da Silveira Cruz-Machado, C.E. Carvalho-Sousa, E.K. Tamura, L. Pinato, E. Cecon, P.A. Fernandes, M.C. de Avellar, Z.S. Ferreira, and R.P. Markus TLR4 and CD14 receptors expressed in rat pineal gland trigger NFKB pathway J. Pineal Res. 49 2010 183 192
13. G.A. Donnan, M. Fisher, M. Macleod, and S.M. Davis Stroke Lancet 371 2008 1612 1623
14. S.J. Ebong, S.M. Goyert, J.A. Nemzek, J. Kim, G.L. Bolgos, and D.G. Remick Critical role of CD14 for production of proinflammatory cytokines and cytokine inhibitors during sepsis with failure to alter morbidity or mortality Infect. Immun. 69 2001 2099 2106
15. K. Fassbender, S. Walter, S. Kuhl, R. Landmann, K. Ishii, T. Bertsch, A.K. Stalder, F. Muehlhauser, Y. Liu, A.J. Ulmer, S. Rivest, A. Lentschat, E. Gulbins, M. Jucker, M. Staufenbiel, K. Brechtel, J. Walter, G. Multhaup, B. Penke, Y. Adachi, T. Hartmann, and K. Beyreuther The LPS receptor (CD14) links innate immunity with Alzheimer's disease FASEB J. 18 2004 203 205
16. K. Fehsel, V. Kolb-Bachofen, and H. Kolb Analysis of TNF alpha-induced DNA strand breaks at the single cell level Am. J. Pathol. 139 1991 251 254
17. E. Galea, D.L. Feinstein, and D.J. Reis Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures Proc. Natl. Acad. Sci. U.S.A. 89 1992 10945 10949
18. A. Haghparast, K.M. Heidari, and A.M. Malvandi Down-regulation of CD14 transcripts in human glioblastoma cell line U87 MG Iran J. Immunol. 8 2011 111 119
19. A. Henn, S. Lund, M. Hedtjarn, A. Schrattenholz, P. Porzgen, and M. Leist The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation ALTEX 26 2009 83 94
20. K. Hyakkoku, J. Hamanaka, K. Tsuruma, M. Shimazawa, H. Tanaka, S. Uematsu, S. Akira, N. Inagaki, H. Nagai, and H. Hara Toll-like receptor 4 (TLR4), but not TLR3 or TLR9 knock-out mice have neuroprotective effects against focal cerebral ischemia Neuroscience 171 2010 258 267
21. G.B. Johnson, G.J. Brunn, and J.L. Platt Activation of mammalian Toll-like receptors by endogenous agonists Crit. Rev. Immunol. 23 2003 15 44
22. J. Jordan, T. Segura, D. Brea, M.F. Galindo, and J. Castillo Inflammation as therapeutic objective in stroke Curr. Pharm. Des. 14 2008 3549 3564
23. A. Jurewicz, M. Matysiak, K. Tybor, L. Kilianek, C.S. Raine, and K. Selmaj Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor Brain 128 2005 2675 2688
24. D.J. Kaczorowski, A. Nakao, R. Vallabhaneni, K.P. Mollen, R. Sugimoto, J. Kohmoto, B.S. Zuckerbraun, K.R. McCurry, and T.R. Billiar Mechanisms of Toll-like receptor 4 (TLR4)-mediated inflammation after cold ischemia/reperfusion in the heart Transplantation 87 2009 1455 1463
25. B.A. Kallmann, R. Malzkorn, and H. Kolb Exogenous nitric oxide modulates cytokine production in human leukocytes J. Life Sci. 65 1999 1787 1794
26. R.G. Knowles, and S. Moncada Nitric oxide synthases in mammals Biochem. J. 298 Pt 2 1994 249 258
27. S.E. Lakhan, A. Kirchgessner, and M. Hofer Inflammatory mechanisms in ischemic stroke: therapeutic approaches J. Transl. Med. 7 2009 97
28. S. Lehnardt, L. Massillon, P. Follett, F.E. Jensen, R. Ratan, P.A. Rosenberg, J.J. Volpe, and T. Vartanian Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway Proc. Natl. Acad. Sci. U.S.A. 100 2003 8514 8519
29. F. Liu, and L.D. McCullough Middle cerebral artery occlusion model in rodents: methods and potential pitfalls J. Biomed. Biotechnol. 2011 2011 464701
30. T. Liu, R.K. Clark, P.C. McDonnell, P.R. Young, R.F. White, F.C. Barone, and G.Z. Feuerstein Tumor necrosis factor-alpha expression in ischemic neurons Stroke 25 1994 1481 1488
31. E.H. Lo, T. Dalkara, and M.A. Moskowitz Mechanisms, challenges and opportunities in stroke Nat. Rev. Neurosci. 4 2003 399 415
32. E. Lorne, H. Dupont, and E. Abraham Toll-like receptors 2 and 4: initiators of non-septic inflammation in critical care medicine? Intensive Care Med. 36 2010 1826 1835
33. G. Magrinat, S.N. Mason, P.J. Shami, and J.B. Weinberg Nitric oxide modulation of human leukemia cell differentiation and gene expression Blood 80 1992 1880 1884
34. M.E. Meistrell 3rd, G.I. Botchkina, H. Wang, S.E. Di, K.M. Cockroft, O. Bloom, J.M. Vishnubhakat, P. Ghezzi, and K.J. Tracey Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia Shock 8 1997 341 348
35. D. Milatovic, S. Zaja-Milatovic, K.S. Montine, F.S. Shie, and T.J. Montine Neuronal oxidative damage and dendritic degeneration following activation of CD14-dependent innate immune response in vivo J. Neuroinflam. 1 2004 20
36. M.A. Moro, A. Cardenas, O. Hurtado, J.C. Leza, and I. Lizasoain Role of nitric oxide after brain ischaemia Cell Calcium 36 2004 265 275
37. K.W. Muir, P. Tyrrell, N. Sattar, and E. Warburton Inflammation and ischaemic stroke Curr. Opin. Neurol. 20 2007 334 342
38. S. Nadeau, and S. Rivest Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and nuclear factor kappa B activity in the brain during endotoxemia J. Neurosci. 20 2000 3456 3468
39. K.C. Ng, S.M. Moochhala, S. Md, E.L. Yap, S.Y. Low, and J. Lu Preservation of neurological functions by nitric oxide synthase inhibitors following hemorrhagic shock Neuropharmacology 44 2003 244 252
40. A. Nurmi, P.J. Lindsberg, M. Koistinaho, W. Zhang, E. Juettler, M.L. Karjalainen-Lindsberg, F. Weih, N. Frank, M. Schwaninger, and J. Koistinaho Nuclear factor-kappaB contributes to infarction after permanent focal ischemia Stroke 35 2004 987 991
41. E. Okun, K.J. Griffioen, J.D. Lathia, S.C. Tang, M.P. Mattson, and T.V. Arumugam Toll-like receptors in neurodegeneration Brain Res. Rev. 59 2009 278 292
42. V.H. Perry, P.B. Andersson, and S. Gordon Macrophages and inflammation in the central nervous system Trends Neurosci. 16 1993 268 273
43. Z.H. Qin, L.Y. Tao, and X. Chen Dual roles of NF-kappaB in cell survival and implications of NF-kappaB inhibitors in neuroprotective therapy Acta. Pharmacol. Sin. 28 2007 1859 1872
44. E.G. Reed-Geaghan, J.C. Savage, A.G. Hise, and G.E. Landreth CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation J. Neurosci. 29 2009 11982 11992
45. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, E.J. Benjamin, J.D. Berry, W.B. Borden, D.M. Bravata, S. Dai, E.S. Ford, C.S. Fox, H.J. Fullerton, C. Gillespie, S.M. Hailpern, J.A. Heit, V.J. Howard, B.M. Kissela, S.J. Kittner, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, D.M. Makuc, G.M. Marcus, A. Marelli, D.B. Matchar, C.S. Moy, D. Mozaffarian, M.E. Mussolino, G. Nichol, N.P. Paynter, E.Z. Soliman, P.D. Sorlie, N. Sotoodehnia, T.N. Turan, S.S. Virani, N.D. Wong, D. Woo, and M.B. Turner Heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 2012 e2 e220
46. R.N. Saha, and K. Pahan Regulation of inducible nitric oxide synthase gene in glial cells Antioxid. Redox. Signal. 8 2006 929 947
47. A.F. Samdani, T.M. Dawson, and V.L. Dawson Nitric oxide synthase in models of focal ischemia Stroke 28 1997 1283 1288
48. A. Schneider, A. Martin-Villalba, F. Wieh, J. Vogel, T. Wirth, and M. Schwaninger NF-κB is activated and promotes cell death in focal cerebral ischemia Nat. Med. 5 1999 554 559
49. B.K. Siesjo Pathophysiology and treatment of focal cerebral ischemia Part I: Pathophysiology, J. Neurosurg. 77 1992 169 184
50. B.K. Siesjo Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment J. Neurosurg. 77 1992 337 354
51. G. Stoll, S. Jander, and M. Schroeter Inflammation and glial responses in ischemic brain lesions Prog. Neurobiol. 56 1998 149 171
52. L. Wang, X. Zhang, L. Liu, R. Yang, L. Cui, and M. Li Atorvastatin protects rat brains against permanent focal ischemia and downregulates HMGB1, HMGB1 receptors (RAGE and TLR4), NF-kappaB expression Neurosci. Lett. 471 2010 152 156
53. Q. Wang, X.N. Tang, and M.A. Yenari The inflammatory response in stroke J. Neuroimmunol. 184 2007 53 68
54. X. Ye, M. Chopp, X. Liu, A. Zacharek, X. Cui, T. Yan, C. Roberts, and J. Chen Niaspan reduces high-mobility group box 1/receptor for advanced glycation endproducts after stroke in type-1 diabetic rats Neuroscience 190 2011 339 345
55. F. Zhang, R.M. Casey, M.E. Ross, and C. Iadecola Aminoguanidine ameliorates and l-arginine worsens brain damage from intraluminal middle cerebral artery occlusion Stroke 27 1996 317 323
56. G. Zhang, and S. Ghosh Molecular mechanisms of NF-kappaB activation induced by bacterial lipopolysaccharide through Toll-like receptors J. Endotoxin. Res. 6 2000 453 457
57. X. Zhao, C. Haensel, E. Araki, M.E. Ross, and C. Iadecola Gene-dosing effect and persistence of reduction in ischemic brain injury in mice lacking inducible nitric oxide synthase Brain Res. 872 2000 215 218